Categories
- All
- Animal & Veterinary
- Award
- Biologics
- Coronavirus
- Cosmetics
- Design
- Dietary Supplements
- Drugs
- Follow @FDAmedia on Twitter
- Follow @FDAMedia on X
- Follow @US_FDA on Twitter
- Follow @US_FDA on X
- Follow FDA on Facebook
- Food & Beverages
- Healthy
- Hotel
- Infant Formula & Foods
- Infectious Disease
- Lifestyle
- Medical Devices
- Nature
- Office
- Over-the-Counter Drugs
- Tobacco
- Training
- Travel Tips
- Travel Tips
- Vaccines
Filter Articles
Search by title or filter by category
911 articles found
-
FDA Roundup: July 14, 2023Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA re-issued two temporary guidances originally published during the... -
FDA Approves First Nonprescription Daily Oral ContraceptiveToday, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a... -
FDA Roundup: July 11, 2023Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA’s Center for Veterinary Medicine (CVM) detailed how it is working to sto... -
FDA Roundup: July 7, 2023Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the U.S. Embassy & Consulates in India published a news release highlighting "Op... -
FDA Converts Novel Alzheimer’s Disease Treatment to Traditional ApprovalToday, the U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a co... -
FDA, FTC Warn Six Companies for Illegally Selling Copycat Food Products Containing Delta-8 THCToday, the U.S. Food and Drug Administration and the Federal Trade Commission issued warning letters to six companies for illegally selling copycat food products containing Delta-8 tetrahydrocannabino... -
FDA Roundup: June 30, 2023Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA’s Center for Tobacco Products (CTP) Director Brian King published... -
FDA Provides Update on Proposal for Unified Human Foods Program, including New Model for the Office of Regulatory AffairsToday, the U.S. Food and Drug Administration is providing an update on its proposal to create a unified Human Foods Program (HFP), which includes a new model for the Office of Regulatory Affairs (ORA)... -
FDA Roundup: June 27, 2023Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published new frequently asked questions and additional tools to provide... -
FDA Issues First Draft Guidance on Clinical Trials with Psychedelic DrugsToday, the U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs for potential treatment of...